Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel AssociationHilde Brems, Douglas R. Stewart|Cancer Research|2009Cited by 137
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Helen Hanson, Douglas R. Stewart, Laura M. Amendola et al.|Genetics in Medicine|2023Cited by 79
Genomic ascertainment of <i>CHEK2</i> -related cancer predispositionSun Young Kim, Douglas R. Stewart|medRxiv|2024Cited by 1